Two Sigma Advisers’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-124,500
| Closed | -$2.05M | – | 2387 |
|
|
2023
Q2 | $2.05M | Buy |
124,500
+18,800
| +18% | +$310K | 0.01% | 1187 |
|
|
2023
Q1 | $968K | Buy |
105,700
+12,600
| +14% | +$115K | ﹤0.01% | 1648 |
|
|
2022
Q4 | $667K | Sell |
93,100
-2,700
| -3% | -$19.3K | ﹤0.01% | 1763 |
|
|
2022
Q3 | $480K | Buy |
95,800
+66,300
| +225% | +$332K | ﹤0.01% | 1856 |
|
|
2022
Q2 | $72K | Buy |
+29,500
| New | +$72K | ﹤0.01% | 2431 |
|